LiquiClear©

 

The core of the LiquiClear© platform is an intravascular membrane catheter with an integrated micro-pump drive for exchanging substances with the patient’s blood. This innovative system was assessed by the World Intellectual Property Organization to be novel and inventive. Major international patents are pending.

With LiquiClear© as a foundation, CCORE developed a minimally invasive, simple, and safe system for intracorporeal blood purification. We aim to develop and market products that require comparatively low investment costs for the operator and can be used without specialized medical knowledge. This will ensure widespread adoption of the devices instead of limiting their use to highly specialized care centers.

CCORE’s first product built on this foundation is a minimally invasive catheter for intravascular removal of carbon dioxide from the bloodstream. This product is known as the Minimally Invasive Liquid Lung or MILL.

 

LiquiClear©

The core of the LiquiClear© platform is an intravascular membrane catheter with an integrated micro-pump drive for exchanging substances with the patient’s blood. This innovative system was assessed by the World Intellectual Property Organization to be novel and inventive. Major international patents are pending.

With LiquiClear© as a foundation, CCORE developed a minimally invasive, simple, and safe system for intracorporeal blood purification. We aim to develop and market products that require comparatively low investment costs for the operator and can be used without specialized medical knowledge. This will ensure widespread adoption of the devices instead of limiting their use to highly specialized care centers.

CCORE’s first product built on this foundation is a minimally invasive catheter for intravascular removal of carbon dioxide from the bloodstream. This product is known as the Minimally Invasive Liquid Lung or MILL.